We analyzed dose distributions for patients with prostate cancer and hip prosthesis.
Conversions of plans from HT to IMRT by SharePlan software were examined.
Dose distributions form converted plans are comparable to doses from HT.
Dose distributions from manually generated plans are worse than for converted plans.